Total Payments
$12,697
2024 Payments
$1,884
Companies
42
Transactions
758
Medicare Patients
1,958
Medicare Billing
$219,944
Payment Breakdown by Category
Food & Beverage$11,836 (93.2%)
Consulting$650.00 (5.1%)
Gifts$124.97 (1.0%)
Education$86.57 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,836 | 747 | 93.2% |
| Consulting Fee | $650.00 | 2 | 5.1% |
| Gift | $124.97 | 5 | 1.0% |
| Education | $86.57 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,489 | 165 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,776 | 72 | $0 (2024) |
| PFIZER INC. | $1,442 | 109 | $0 (2024) |
| Gilead Sciences, Inc. | $1,364 | 87 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,045 | 60 | $0 (2024) |
| Merck Sharp & Dohme LLC | $527.42 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $521.67 | 30 | $0 (2024) |
| Celgene Corporation | $356.46 | 19 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $313.87 | 20 | $0 (2023) |
| Daiichi Sankyo Inc. | $260.60 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,884 | 101 | ABBVIE INC. ($438.63) |
| 2023 | $1,719 | 100 | AbbVie Inc. ($406.02) |
| 2022 | $2,058 | 115 | ABBVIE INC. ($522.09) |
| 2021 | $1,948 | 122 | AbbVie Inc. ($361.56) |
| 2020 | $998.75 | 72 | AbbVie Inc. ($188.77) |
| 2019 | $1,407 | 96 | PFIZER INC. ($332.86) |
| 2018 | $1,282 | 71 | Takeda Pharmaceuticals U.S.A., Inc. ($441.34) |
| 2017 | $1,401 | 81 | Takeda Pharmaceuticals U.S.A., Inc. ($325.00) |
All Payment Transactions
758 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: VIROLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.65 | General |
| 10/24/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Immunology | ||||||
| 09/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/17/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $80.97 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 492 | 557 | $286,322 | $58,456 |
| 2022 | 13 | 488 | 540 | $281,875 | $53,985 |
| 2021 | 13 | 517 | 595 | $293,500 | $61,967 |
| 2020 | 13 | 461 | 530 | $228,175 | $45,536 |
Total Patients
1,958
Total Services
2,222
Medicare Billing
$219,944
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 161 | $33,150 | $14,761 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $22,500 | $8,248 | 36.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 32 | 32 | $28,700 | $5,624 | 19.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 25 | 26 | $32,240 | $5,328 | 16.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 30 | 30 | $27,335 | $5,177 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 73 | $10,882 | $4,549 | 41.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 59 | $44,250 | $4,336 | 9.8% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 29 | 29 | $35,815 | $3,541 | 9.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $21,800 | $3,124 | 14.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 22 | 22 | $26,950 | $2,670 | 9.9% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 13 | 13 | $1,300 | $986.23 | 75.9% |
| 87077 | Bacterial culture for aerobic isolates | Facility | 2023 | 14 | 14 | $1,400 | $110.88 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 127 | $26,350 | $11,348 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $17,400 | $6,491 | 37.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 33 | 33 | $29,700 | $5,781 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 81 | $12,150 | $5,242 | 43.1% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 34 | 34 | $41,990 | $4,859 | 11.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 59 | 63 | $47,250 | $3,893 | 8.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 31 | 31 | $37,975 | $3,816 | 10.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 19 | $23,560 | $3,723 | 15.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,950 | $2,897 | 48.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $21,850 | $2,603 | 11.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $12,600 | $2,326 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,200 | $773.58 | 35.2% |
| 87077 | Bacterial culture for aerobic isolates | Facility | 2022 | 29 | 29 | $2,900 | $231.84 | 8.0% |
About Dr. Hirendra Doshi, M.D
Dr. Hirendra Doshi, M.D is a Specialist healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356312664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hirendra Doshi, M.D has received a total of $12,697 in payments from pharmaceutical and medical device companies, with $1,884 received in 2024. These payments were reported across 758 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($11,836).
As a Medicare-enrolled provider, Doshi has provided services to 1,958 Medicare beneficiaries, totaling 2,222 services with total Medicare billing of $219,944. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Raleigh, NC
- Active Since 01/27/2006
- Last Updated 04/22/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1356312664
Products in Payments
- XELJANZ (Drug) $1,089
- Entyvio (Biological) $808.21
- ENTYVIO (Biological) $763.41
- STELARA (Biological) $610.77
- XIFAXAN (Drug) $553.02
- RINVOQ (Biological) $459.92
- LINZESS (Drug) $406.72
- DIFICID (Drug) $385.26
- ZEPOSIA (Drug) $383.17
- HUMIRA (Biological) $381.85
- TRULANCE (Drug) $340.01
- CREON (Drug) $249.12
- SKYRIZI (Biological) $245.39
- INJECTAFER (Drug) $235.57
- Cimzia (Drug) $233.09
- ZENPEP (Drug) $200.80
- INFLECTRA (Biological) $194.51
- OCALIVA (Drug) $187.33
- Creon (Drug) $173.12
- MAVYRET (Drug) $167.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Raleigh
Dr. A. Silvia Ross, M.d, M.D
Specialist — Payments: $426,241
Specialist $426,241
Dr. Dennis Bullard, M.d, M.D
Specialist — Payments: $281,071
Specialist $281,071
Dr. Michael Law, Md, MD
Specialist — Payments: $83,288
Specialist $83,288
Dr. Glenn Davis, Md, MD
Specialist — Payments: $33,080
Specialist $33,080
Dr. Dorian Defreitas, Md, MD
Specialist — Payments: $25,004
Specialist $25,004
Sherry Sinclair, M.d, M.D
Specialist — Payments: $20,106
Specialist $20,106